Klotho Neurosciences, Inc.
KLTO
$0.1748
-$0.0069-3.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 817.19% | 570.40% | 110.58% | 90.64% | 9.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 817.19% | 570.40% | 110.58% | 90.64% | 9.91% |
| Operating Income | -817.19% | -570.40% | -110.58% | -90.64% | -9.91% |
| Income Before Tax | -769.30% | -514.62% | -104.22% | -86.35% | -18.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -769.30% | -514.62% | -104.22% | -86.35% | -18.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -769.30% | -514.62% | -104.22% | -86.35% | -18.19% |
| EBIT | -817.19% | -570.40% | -110.58% | -90.64% | -9.91% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -693.82% | -687.91% | -164.25% | -5,900.00% | -7,020.00% |
| Normalized Basic EPS | -695.95% | -685.96% | -164.29% | -5,525.00% | -5,450.00% |
| EPS Diluted | -656.76% | -689.21% | -175.98% | -6,250.00% | -7,440.00% |
| Normalized Diluted EPS | -695.95% | -685.96% | -164.29% | -5,525.00% | -5,450.00% |
| Average Basic Shares Outstanding | 1.30% | -48.47% | -65.37% | -73.91% | -73.91% |
| Average Diluted Shares Outstanding | 1.30% | -48.47% | -65.37% | -73.91% | -73.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |